Cargando…

Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer

BACKGROUND: Paraneoplastic syndromes are most frequently associated with small cell lung carcinoma, hematologic and gynecologic malignancies while reports in head and neck cancer are rare. CASE PRESENTATION: We present the case of a 60-year old female patient who developed paraneoplastic cerebellar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huemer, Florian, Melchardt, Thomas, Tränkenschuh, Wolfgang, Neureiter, Daniel, Moser, Gerhard, Magnes, Teresa, Weiss, Lukas, Schlattau, Alexander, Hufnagl, Clemens, Ricken, Gerda, Höftberger, Romana, Greil, Richard, Egle, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687318/ https://www.ncbi.nlm.nih.gov/pubmed/26694863 http://dx.doi.org/10.1186/s12885-015-2020-4

Ejemplares similares

CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
por: Melchardt, Thomas, et al.
Publicado: (2015)

Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies
por: Winklehner, Michael, et al.
Publicado: (2022)

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones
por: Melchardt, Thomas, et al.
Publicado: (2016)

Liver toxicity during temozolomide chemotherapy caused by Chinese herbs
por: Melchardt, Thomas, et al.
Publicado: (2014)

Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
por: Magnes, T., et al.
Publicado: (2019)

Antibody Repertoire in Paraneoplastic Cerebellar Degeneration and Small Cell Lung Cancer
por: Sabater, Lidia, et al.
Publicado: (2013)

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy
por: Magnes, Teresa, et al.
Publicado: (2017)

Update on Paraneoplastic Cerebellar Degeneration
por: Loehrer, Philipp Alexander, et al.
Publicado: (2021)

C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients
por: Schlick, Konstantin, et al.
Publicado: (2019)

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017
por: Magnes, Teresa, et al.
Publicado: (2017)

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia: A case report
por: Huemer, Florian, et al.
Publicado: (2016)

Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence
por: Magnes, T., et al.
Publicado: (2021)

Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
por: Rinnerthaler, Gabriel, et al.
Publicado: (2020)

Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies
por: Magnes, Teresa, et al.
Publicado: (2021)

Treatment of Paraneoplastic Cerebellar Degeneration
por: Greenlee, John E.
Publicado: (2013)

The Role of Neutrophilic Granulocytes in Philadelphia Chromosome Negative Myeloproliferative Neoplasms
por: Kiem, Dominik, et al.
Publicado: (2021)

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters
por: Schlick, Konstantin, et al.
Publicado: (2018)

Paraneoplastic cerebellar degeneration in Hodgkin's lymphoma
por: Suri, Vinit, et al.
Publicado: (2012)

Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: Case report
por: Abdulaziz, Ammar Taha Abdullah, et al.
Publicado: (2018)

Paraneoplastic cerebellar degeneration associated with ovarian cancer
por: RUSSO, ALESSIA ERIKA, et al.
Publicado: (2013)

Paraneoplastic cerebellar degeneration associated with lymphoepithelial carcinoma of the tonsil
por: Henke, Christian, et al.
Publicado: (2013)

Tremor in Paraneoplastic Cerebellar Degeneration: Beyond Intention Tremor
por: Gupta, Harsh V., et al.
Publicado: (2020)

Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications
por: Yshii, Lidia, et al.
Publicado: (2020)

Transient Diffusion-weighted Imaging Hyperintensity of the Cerebellar Cortex in Paraneoplastic Cerebellar Degeneration
por: Hashimoto, Yasumasa, et al.
Publicado: (2018)

Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy
por: Kiem, Dominik, et al.
Publicado: (2021)

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL‐2 and/or BIM
por: Huemer, Florian, et al.
Publicado: (2019)

Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone: Analysis of the Austrian head and neck cancer registry of the AGMT
por: Magnes, Teresa, et al.
Publicado: (2021)

Paraneoplastic cerebellar degeneration associated with noncutaneous Merkel cell carcinoma
por: Zhang, Cen, et al.
Publicado: (2014)

Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
por: Berzero, Giulia, et al.
Publicado: (2017)

Paraneoplastic cerebellar degeneration with anti‐Yo antibodies – a review
por: Venkatraman, Anand, et al.
Publicado: (2016)

Paraneoplastic cerebellar degeneration as initial presentation of renal cell carcinoma
por: Souza, Sara M., et al.
Publicado: (2019)

Ovarian cancer revealed by paraneoplastic cerebellar degeneration: a case report
por: Elomrani, Fadwa, et al.
Publicado: (2014)

A rare case of breast carcinoma presenting with paraneoplastic cerebellar degeneration
por: Eseonu, Kelechi, et al.
Publicado: (2010)

Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration
por: Probst, Christian, et al.
Publicado: (2015)

Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration
por: Herdlevær, Ida, et al.
Publicado: (2020)

A Rare Coexistence of Paraneoplastic Cerebellar Degeneration: Papillary Thyroid Carcinoma
por: Ayas, Zeynep Özözen, et al.
Publicado: (2021)

Paraneoplastic cerebellar degeneration as a presenting manifestation of non-Hodgkin’s lymphoma
por: Nanda, Satyan, et al.
Publicado: (2021)

How I treat diffuse large B-cell lymphoma
por: Melchardt, T., et al.
Publicado: (2023)

CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration
por: Eichler, Tilo W., et al.
Publicado: (2013)

Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity
por: Panja, D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5mcf7klncs5tbbu7gi3sa3emb7